Holen Sie sich die Stockscreener-App
13.44
0.15%
-0.02
Vorhandelsmarkt:
13.40
-0.04
-0.30%
Schlusskurs vom Vortag:
$13.46
Offen:
$13.52
24-Stunden-Volumen:
4.39M
Relative Volume:
0.78
Marktkapitalisierung:
$6.67B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
33.60
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+0.30%
1M Leistung:
+37.85%
6M Leistung:
+9.71%
1J Leistung:
-26.15%
1-Tages-Spanne:
$13.41
$13.69
1-Wochen-Bereich:
$13.09
$14.20
52-Wochen-Spanne:
$8.02
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
13.44 | 6.66B | 4.45B | 205.00M | 372.00M | 0.40 |
|
HLN
Haleon Plc Adr
|
10.93 | 50.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
168.59 | 73.64B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.92 | 4.12M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.57B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.52 | 20.82B | 16.54B | -1.64B | 749.00M | -1.45 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief | ELAN Stock News - GuruFocus
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief - Quantisnow
Equine Healthcare Market Analysis: Trends, Key Players, - openPR.com
Animal Depression Medication Market Detailed in New Research Report | Zoetis Inc., Elanco Animal Health - openPR.com
Ameriprise Financial Inc. Has $1.18 Million Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Companion Animal Health Market -Depth Analysis, Future Trends - openPR.com
Veterinary Vaccines Market Size, Share & Forecast 2025-2033 | - openPR.com
Cetera Investment Advisers Purchases 4,553 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco at Stifel Jaws & Paws: Strategic Growth and Innovation By Investing.com - Investing.com Canada
Elanco appoints Robert VanHimbergen as chief financial officer - Feed Strategy
Elanco appoints VanHimbergen as CFO - Feedstuffs
Transcript : Elanco Animal Health Incorporated Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 08 - marketscreener.com
Elanco names Robert VanHimbergen as new CFO By Investing.com - Investing.com South Africa
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer - The Malaysian Reserve
How Elanco Plans on Winning in the Pet Wellness Boom - marketscreener.com
Elanco Animal Health Incorporated Announces Change of Executive Vice President - marketscreener.com
Elanco Animal Health Incorporated Reconfirms Earnings Guidance for the Second Quarter and Full Year 2025 - marketscreener.com
Elanco Animal Health Appoints Robert VanHimbergen As CFO, Reaffirms Q2, FY25 Guidance - Nasdaq
Elanco (ELAN) Names Robert VanHimbergen as New CFO | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Maintains Revenue and Earnings Outlo - GuruFocus
Elanco Animal Health (ELAN) Reaffirms FY25 Revenue and EBITDA Ou - GuruFocus
Elanco Appoints New CFO to Drive Growth - TipRanks
Elanco names Robert VanHimbergen as new CFO - Investing.com
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Reaffirms FY25 Revenue and EBITDA Outlook | ELAN Stock News - GuruFocus
Elanco Animal Health Incorporated filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
Elanco Animal Health (ELAN) Appoints Robert VanHimbergen as CFO - StreetInsider
Veterinary Dermatology Market to Hit US$30.31 Billion by 2030 with 8.5% CAGR | MarketsandMarkets - The Globe and Mail
Elanco Animal Health Inc (ELAN) Shares Up 4.34% on May 27 - GuruFocus
Animal Healthcare Market Deep Research Report Outlines Growth TrajectoryZoetis, Elanco - openPR.com
Poultry Pharmaceuticals Market Is Booming Worldwide | Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health - openPR.com
Elanco Animal Health Incorporated Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationELAN - ACCESS Newswire
Shareholders that lost money on Elanco Animal Health Incorporated(ELAN) should contact Levi & Korsinsky about pending Class ActionELAN - ACCESS Newswire
BNP Paribas Financial Markets Sells 204,974 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco at BNP Paribas Animal Health Day: Strategic Growth and Innovation - Investing.com Nigeria
Transcript : Elanco Animal Health Incorporated Presents at BNP Paribas 2nd Annual Animal Health Day, May-22-2025 12 - marketscreener.com
Udder Health Market Detailed in New Research Report By 2032 | - openPR.com
Veterinary Dermatology Market Set to Witness Significant - openPR.com
TD Cowen Adjusts Elanco Animal Health Price Target to $15 From $12, Maintains Buy Rating - marketscreener.com
Elanco (ELAN) Receives Price Target Boost from TD Cowen Analyst | ELAN Stock News - GuruFocus
Janus Henderson Group PLC Sells 8,600 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Bank of America Corp DE Sells 430,146 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Animal Health (NYSE:ELAN) Given New $16.00 Price Target at Stifel Nicolaus - Defense World
Elanco Animal Health (ELAN) Sees Target Price Boost by Stifel | ELAN Stock News - GuruFocus
Elanco (ELAN) Price Target Increased by Stifel | ELAN Stock News - GuruFocus
Elanco to Participate in the Upcoming Investor Conferences | ELAN Stock News - GuruFocus
Elanco to Participate in the Upcoming Investor Conferences - Nasdaq
Comerica Bank Acquires 26,517 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Leadership Takes Center Stage: Key Updates Coming at BNP Paribas and Stifel Conferences - Stock Titan
Veterinary Medicine Market Generated Opportunities, Future - openPR.com
S&P 500 Futures Drop in Premarket Trading; Dick's Sporting Goods, Elanco Animal Health Lag - Barron's
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):